Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study

Detalles Bibliográficos
Autores principales: Ishida, Tadao, Ito, Shigeki, Tanaka, Junji, Uchiyama, Michihiro, Kawano, Yawara, Moreau, Philippe, Martin, Thomas, Risse, Marie-Laure, Tada, Keisuke, Suzuki, Kenshi, Ishizawa, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721457/
https://www.ncbi.nlm.nih.gov/pubmed/36073950
http://dx.doi.org/10.1093/jjco/hyac137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721457/
https://www.ncbi.nlm.nih.gov/pubmed/36073950
http://dx.doi.org/10.1093/jjco/hyac137

Ejemplares similares